Condition : Chronic Lymphocytic Leukemia Intervention : Biological: TRU-016 and rituximab Sponsors : Emergent Product Development Seattle LLC; Emergent Product Development Seattle LLC Not yet recruiting – verified July 2012
Read More...Cancer News
- Bladder Cancer (65)
- Brain Tumor Cancer (38)
- Breast Cancer (8038)
- Cancer Bulletins (543)
- Cancer Clinical Trials (5106)
- Cancer Treatment (1202)
- Colon Rectal Cancer (5952)
- General Cancer (16831)
- Leukemia Lymphoma Cancer (10577)
- Lung Mesothelioma Asbestos (4828)
- Ovarian Cervical Uterine Cancer (1140)
- Pancreatic Cancer (56)
- Prostate Cancer (6895)
- Skin Cancer (6033)
- Uncategorized (53)
-
Cancer News Topics
- Man walks across America for ovarian cancer awareness
- Does ovarian cancer risk necessitate ovary removal [NBC 5-15-2013]
- Cervical cancer vaccination for school girls welcomed
- What Is Colon Cancer? Mitchel P. Goldman, MD, Explains
- The Local Show (skin cancer special) pt. 1 – May 16, 2013
- Skin Cancer Facts That Can Save Your Life
- The Dangers of Skin Cancer
- Chronic Lymphocytic Leukemia Epigenome (Revised version)
- Healing Leukemia#30~ My Cancer Cleanse Maintenance Juice Recipe
- Dr. Swords featuring new Chronic Myeloid Leukemia (CML) Drug
- 4-year-old who had leukemia has wish granted: Charlotte Grimm danced with ballerinas downtown
- RSTV: Geno Shelton- raises money for Leukemia patient
- Small cancer risk following CT scans in childhood and adolescence confirmed
- DNA damage: The dark side of respiration
- Cold plasma successful against brain cancer cells, study suggests
- Inexpensive, accurate way to detect prostate cancer: At-home urine tests
- ‘Doors’ Founder Ray Manzarek Traveled to Germany for Special Cancer Treatment
- Cancer Treatment and Survivorship in Women Under 40 – Dr. Freya R. Schnabel
- What’s in Your Sunscreen?
- How you can help us hit our Crocus Cancer Appeal target
- Genetic diversity predicts outcomes in head and neck cancer
- Epigenetic Regulators And NF-Kappa B May One Day Be Targeted For The Treatment Of Cancer
- Everyone, Including Mesothelioma Patients, Should Plan for End-of-Life Care
- Cancer and birth defects in Iraq: The nuclear legacy
- New factor to control oncogene-induced senescence discovered
PIVOT Prostate Cancer Study Should Empower Men to Make Informed Decisions
An important study published in the New England Journal of Medicine (NEJM) addresses the use of the prostate-specific antigen test, or PSA test, for early detection and the challenges regarding proper early detection and early treatment of prostate cancer in the PSA era. The main take-home message? Men should be empowered to make informed decisions about their treatment. For more, including a written commentary, click here: www.roswellpark.org